Origins and Benefits of Biologically Active Components in Human Milk
母乳中生物活性成分的来源和益处
基本信息
- 批准号:10683486
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAffectAgeAwardBig DataBiologyBrainCategoriesCharacteristicsChild NutritionCognitionCollaborationsCommunicable DiseasesDevelopmentDiseaseEnsureFloridaFutureGoalsGovernmentHuman MilkHypersensitivityImmuneIndustryInfantInfant HealthInfant formulaLactationLengthMammary glandMaternal HealthMembraneMetabolic DiseasesMothersNational Institute of Allergy and Infectious DiseaseNational Institute of Child Health and Human DevelopmentNational Institute of Diabetes and Digestive and Kidney DiseasesNatureNutrientOligosaccharidesOralPersonsPoliciesPregnancyPremature InfantPropertyResearchResearch PersonnelSafetyScienceSourceStrategic PlanningStudentsTravelUnderrepresented PopulationsUnited States National Institutes of Healthcareercareer developmentcollaborative environmentcomplex biological systemseffective therapygut healthimprovedinnovationinterestmilk fat globulemother nutritionnext generationnovelnutritionpostersprofessional studentssymposiumtechnological innovationtechnology development
项目摘要
PROJECT SUMMARY
The 5th FASEB Science Research Conference (SRC) on “Origins and Benefits of Biologically
Active Components in Human Milk” in Melbourne, Florida, June 4-9, 2023, will be a gathering of
professionals who wish to deepen their understanding of this scientific topic. The conference will
bring together previous and new speakers/attendees to promote diversity of thought in this space.
The conference has a strong inter-disciplinary nature, with stakeholders from industry, academia
and government coming together to better understand human milk as a complex biological
system with the ultimate goal of improving maternal & infant health.
A majority of the conference sessions will address key scientific research themes and objectives
outlined in the NICHD Strategic Plan 2020: “Of unique interest to the institute [NICHD] is a better
understanding of the composition and function of human milk, the effect of maternal nutrition and
length of gestation on human milk composition and lactation, and the optimal source of nutrition
and mode if nutrient delivery to the infant, especially preterm infants.” In addition, the conference
addresses one of the ten aspirational goals in the NICHD Strategic Plan 2020: “Optimize infant
survival by synthesizing human milk, capturing all its components and properties, and
individualizing it to the characteristics of the infant’s mother.”
Understanding the origins and benefits of human milk components is also relevant to NIH
institutes other than NICHD as they affect gut health and development and metabolic diseases
(NIDDK) and protect from allergy and infectious diseases (NIAID). In fact, human milk
components may serve as templates for novel, safe and effective treatments for diseases in
people of all ages and, therefore, be of relevance to many of the other NIH institutes.
Finally, the conference will offer a strong “career development” focus, supporting students and
early career investigators with their professional ambitions. We therefore specifically aim to
subsidize registration and travel of invited speakers in the early career investigator category and
provide travel awards for students with outstanding abstracts, posters and oral presentations.
Supporting the next generation of researchers, clinicians and educators in the field of human milk
and lactation will ensure that NICHD’s current objectives and aspirational goals will be met not
only today, but also in the future.
项目摘要
第五届FASEB科学研究会议(SRC)关于“生物学的起源和益处”
母乳中的活性成分”将于2023年6月4日至9日在佛罗里达的墨尔本举行,届时将有
希望加深对这一科学主题的理解的专业人士。会议将
将以前和新的演讲者/与会者聚集在一起,以促进这个空间的思想多样性。
该会议具有很强的跨学科性质,来自工业界,学术界,
和政府一起来更好地了解母乳作为一种复杂的生物
该系统的最终目标是改善母婴健康。
大部分会议将讨论关键的科学研究主题和目标
在NICHD战略计划2020中概述:“研究所[NICHD]的独特兴趣是更好的
了解母乳的成分和功能,产妇营养的影响,
妊娠期长短对母乳成分和泌乳的影响,以及最佳营养来源
和模式,如果营养输送给婴儿,特别是早产儿。此外,会议
解决了NICHD 2020年战略计划中的十大目标之一:“优化婴儿
通过合成人乳,捕获其所有成分和特性,
根据婴儿母亲的特点来个性化。”
了解母乳成分的来源和益处也与NIH有关
NICHD以外的其他研究机构,因为它们影响肠道健康和发育以及代谢疾病
(NIDDK)和防止过敏和传染病(NIAID)。事实上,人乳
成分可以作为新的,安全和有效的治疗疾病的模板,
所有年龄段的人,因此,与许多其他NIH研究所相关。
最后,会议将提供一个强大的“职业发展”的重点,支持学生和
有着职业抱负的早期职业调查员因此,我们的具体目标是
为职业早期调查员类别的受邀发言者提供登记和差旅补贴,
为有杰出摘要、海报及口头报告的学生提供旅游奖励。
支持母乳领域的下一代研究人员、临床医生和教育工作者
和哺乳将确保NICHD的当前目标和理想目标将得到满足,
不仅在今天,而且在未来。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lars Bode其他文献
Lars Bode的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lars Bode', 18)}}的其他基金
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
利用药物微生物组学和代谢组学分析优化母亲及其母乳喂养婴儿的抗生素
- 批准号:
10681290 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Exploring Associations between Human Milk Oligosaccharides and Atherosclerosis Risk Factors in Infancy and Early Childhood
探索母乳低聚糖与婴儿期和幼儿期动脉粥样硬化危险因素之间的关联
- 批准号:
10195374 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Exploring Associations between Human Milk Oligosaccharides and Atherosclerosis Risk Factors in Infancy and Early Childhood
探索母乳低聚糖与婴儿期和幼儿期动脉粥样硬化危险因素之间的关联
- 批准号:
10491367 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
利用药物微生物组学和代谢组学分析优化母亲及其母乳喂养婴儿的抗生素
- 批准号:
10659295 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
利用药物微生物组学和代谢组学分析优化母亲及其母乳喂养婴儿的抗生素
- 批准号:
10309708 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
利用药物微生物组学和代谢组学分析优化母亲及其母乳喂养婴儿的抗生素
- 批准号:
10487493 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Exploring human milk oligosaccharides and malaria risk in breastfed infants
探索母乳低聚糖和母乳喂养婴儿的疟疾风险
- 批准号:
10226366 - 财政年份:2020
- 资助金额:
$ 1万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
Research Grant